The Amyloidosis Forum | June 21, 2023 | Afternoon Sessions
Recording of the Afternoon Sessions from the Amyloidosis Forum: Advancing Drug Development in ATTR Amyloidosis in an Evolving Treatment Landscape, hosted at the U.S. Food and Drug Administration's White Oak Campus in Silver Spring, Maryland on June 21, 2023.
For more information, visit: https://amyloidosisforum.org/a....ttr-drug-development
Each session can be viewed at the following timestamps:
0:00 - Approaches to Future Clinical Trial Design (Endpoints)
11:46 - Approaches to Future Clinical Trial Design (Survival)
21:59 - Functional & Patient-Reported Outcomes in ATTR Drug Development
32:45 - How to quantify and interpret the treatment effect in comparative cardiovascular trials with multiple outcomes?
51:11 - Moderated Discussion: Approaches to Future Clinical Trial Design
1:32:43 - Moderated Discussion: Diversity in Research
2:04:58 - Clinical Trials, Drug Development, and Access (Epidemiology)
2:13:44 - The Economics of ATTR Therapies
2:23:50 - Moderated Discussion: Clinical Trials, Drug Development, and Access
2:45:04 - Closing Remarks
Meeting recorded live via Zoom.
-
Category
No comments found